Discovery - Top 10
By people
- 43 tse, hf
- 43 tse, hung fat
- 43 謝鴻發
- 36 ip, m
- 36 ip, mary sau man
- 36 ip, ms
- 36 ip, msm
- 36 ip, sau-man, mary
- 36 葉秀文
- 34 lai, kar neng
HKU Organizations
- 363 li ka shing faculty of medicine
- 337 department of medicine
- 17 department of family medicine and...
- 10 li ka shing faculty of medicine
- 8 school of biomedical sciences
- 5 department of paediatrics and ado...
- 5 department of pharmacology and ph...
- 5 school of clinical medicine
- 4 department of surgery
- 3 department of obstetrics and gyna...
Browse
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 368
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Eosinophilic Disorders and Systemic Mastocytosis Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 | |||
Management of Intestinal-Type Gastric Cancer Book:Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach (2nd edition). | 1-Feb-2024 | |||
Ethical and Legal Aspects of Care for Elders Book:The Hong Kong Geriatric Society Curriculum in Geriatric Medicine | 1-Dec-2017 | |||
Antibiotic resistance, susceptibility testing and stewardship in Helicobacter pylori infection Book:Towards the Eradication of Helicobacter pylori Infection – Rapid Diagnosis and Precision Treatment | 1-Jan-2024 | |||
Treatment Algorithm for Primary and Secondary Myelofibrosis Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 | |||
In the Pipeline: Emerging Therapy for Classical Ph-Negative MPNs Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 | |||
In the Pipeline: Emerging Therapy for CML Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 | |||
Molecular Landscape and Personalized Prognostic Prediction of MPNs Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 | |||
Prognostic Models for Primary and Secondary Myelofibrosis Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 | |||
Allogeneic Hematopoietic Stem Cell Transplantation for MDS and CMML: When and How? Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 | |||
In the Pipeline: Emerging Therapy for MDS and MDS/MPN Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 | |||
Clonal Hematopoiesis and Its Functional Implications in MDS/AML Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 | |||
Prognostic Indicators in MDS and CMML Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 | |||
Management of Relapsed Acute Promyelocytic Leukemia and the Role of Hematopoietic Stem Cell Transplantation Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 | |||
In the Pipeline—Emerging Therapy for ALL Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 | |||
Frontline Management of Acute Promyelocytic Leukemia Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 | |||
Next-Generation FLT3 Inhibitors for the Treatment of FLT3-Positive AML Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 | |||
In the Pipeline: Emerging Therapy for Acute Myeloid Leukaemia Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 | |||
Management of Relapsed or Refractory AML Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 | |||
Role of IDH1/IDH2 Inhibitors in AML Book:Pathogenesis and Treatment of Leukemia | 28-Sep-2023 |
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 368